Processa Pharmaceuticals Insider Trades
NASDAQ: PCSAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 26 · $130.87K
- Sales
- 0 · $0
- Shares bought / sold
- 53.74K / 0
- Net activity
- Net buying $130,867
Processa Pharmaceuticals insider activity
Over the last 12 months, Processa Pharmaceuticals insiders reported 31 transactions on SEC Form 4: 26 open-market purchases and 0 sales. Insiders bought $130,867 and sold $0 worth of stock, for net insider buying of $130,867. The most recent filing shows Ng George K (Chief Executive Officer) reporting a transaction in 1,600 shares on Aug 8, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PCSA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
PCSA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 8, 2026 | Ng George KChief Executive Officer | Option exercise | 1,600 | — | Form 4 |
| Jul 1, 2026 | Ng George KChief Executive Officer | Buy | 3,057 | $5.90K | Form 4 |
| Jun 30, 2026 | Young DavidPres. Research & Development | Buy | 2,531 | $4.88K | Form 4 |
| Jun 30, 2026 | SKIBSTED RUSSELLChief Financial Officer | Buy | 3,277 | $6.32K | Form 4 |
| Jun 30, 2026 | Lin PatrickChief Business - Strategy Off | Buy | 2,106 | $4.06K | Form 4 |
| Jun 30, 2026 | Guy WendyChief Administrative Officer | Buy | 2,436 | $4.70K | Form 4 |
| Jun 26, 2026 | Pannu GeraldineDirector | Option exercise | 203 | — | Form 4 |
| Jun 26, 2026 | Yorke Justin WDirector | Option exercise | 203 | — | Form 4 |
| Jun 26, 2026 | Baluch KhosoDirector | Option exercise | 203 | — | Form 4 |
| Jun 26, 2026 | Neal James RDirector | Option exercise | 203 | — | Form 4 |
| Jun 15, 2026 | Guy WendyChief Administrative Officer | Buy | 2,118 | $4.70K | Form 4 |
| Jun 15, 2026 | Ng George KChief Executive Officer | Buy | 2,465 | $5.47K | Form 4 |
| Jun 15, 2026 | SKIBSTED RUSSELLChief Financial Officer | Buy | 2,654 | $5.89K | Form 4 |
| Jun 15, 2026 | Lin PatrickChief Business - Strategy Off | Buy | 1,831 | $4.06K | Form 4 |
| Jun 15, 2026 | Young DavidPres. Research & Development | Buy | 2,067 | $4.59K | Form 4 |
| May 29, 2026 | Young DavidPres. Research & Development | Buy | 1,786 | $4.59K | Form 4 |
| May 29, 2026 | Lin PatrickChief Business - Strategy Off | Buy | 1,582 | $4.07K | Form 4 |
| May 29, 2026 | Ng George KChief Executive Officer | Buy | 2,129 | $5.47K | Form 4 |
| May 29, 2026 | Guy WendyChief Administrative Officer | Buy | 1,829 | $4.70K | Form 4 |
| May 29, 2026 | SKIBSTED RUSSELLChief Financial Officer | Buy | 2,292 | $5.89K | Form 4 |
| May 15, 2026 | SKIBSTED RUSSELLChief Financial Officer | Buy | 1,984 | $5.89K | Form 4 |
| May 15, 2026 | Lin PatrickChief Business - Strategy Off | Buy | 1,369 | $4.07K | Form 4 |
| May 15, 2026 | Ng George KChief Executive Officer | Buy | 1,843 | $5.47K | Form 4 |
| May 15, 2026 | Guy WendyChief Administrative Officer | Buy | 1,583 | $4.70K | Form 4 |
| May 15, 2026 | Young DavidPres. Research & Development | Buy | 1,545 | $4.59K | Form 4 |
| Apr 30, 2026 | Ng George KChief Executive Officer | Buy | 2,034 | $5.47K | Form 4 |
| Apr 30, 2026 | SKIBSTED RUSSELLChief Financial Officer | Buy | 2,190 | $5.89K | Form 4 |
| Apr 30, 2026 | Young DavidPres. Research & Development | Buy | 1,706 | $4.59K | Form 4 |
| Apr 30, 2026 | Lin PatrickChief Business - Strategy Off | Buy | 1,511 | $4.06K | Form 4 |
| Apr 30, 2026 | Bigora SianChief Development Officer | Buy | 1,971 | $5.34K | Form 4 |
| Apr 15, 2026 | Ng George KChief Executive Officer | Buy | 1,843 | $5.47K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4